Molecular Partners Ag (MOLN) Exchange Rate Effect (2020 - 2026)
Molecular Partners Ag's (MOLN) quarterly Exchange Rate Effect came in at $6326.2 in Q2 2026, up 423.74% year-over-year from $1207.9 in Q2 2025, and up 23.85% quarter-over-quarter from $5108.0 in Q1 2026.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Exchange Rate Effect for 7 consecutive years, with $6326.2 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Exchange Rate Effect rose 423.74% year-over-year to $6326.2 in Q2 2026; TTM through Jun 2026 was -$18597.0, a 65.81% increase from a year earlier, with the FY2025 full-year figure at -$21710.3, up 51.03% from the prior year.
- Exchange Rate Effect was $6326.2 for Q2 2026 at Molecular Partners Ag, up from $5108.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $50892.0 in Q1 2022 and troughed at -$589233.6 in Q1 2023.
- A 5-year average of -$42523.8 and a median of -$6227.1 in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect surged 820.24% in 2022 and sank 1257.81% in 2023, its largest moves.
- Over 5 years, Exchange Rate Effect stood at -$93422.0 in 2022, then soared by 77.07% to -$21419.7 in 2023, then slumped by 54.55% to -$33104.1 in 2024, then slipped by 2.05% to -$33781.6 in 2025, then soared by 118.73% to $6326.2 in 2026.
- The last three Exchange Rate Effect figures came in at $6326.2 (Q2 2026), $5108.0 (Q1 2026), and -$33781.6 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Molecular Partners Ag | 156.54 Mn | 156.54 Mn | - | 6,326.20 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,326.20 |
| Mar 31, 2026 | 5,108.02 |
| Dec 31, 2025 | -33,781.58 |
| Sep 30, 2025 | 3,750.33 |
| Jun 30, 2025 | 1,207.89 |
| Mar 31, 2025 | -15,571.51 |
| Dec 31, 2024 | -33,104.13 |
| Sep 30, 2024 | -6,925.24 |
| Jun 30, 2024 | -5,528.97 |
| Mar 31, 2024 | -28,642.06 |
| Dec 31, 2023 | -21,419.74 |
| Sep 30, 2023 | 2,264.31 |
| Jun 30, 2023 | -1,112.18 |
| Mar 31, 2023 | -589,233.60 |
| Dec 31, 2022 | -93,421.97 |
| Sep 30, 2022 | 2,070.91 |
| Jun 30, 2022 | -8,306.34 |
| Mar 31, 2022 | 50,891.99 |
| Dec 31, 2021 | -159,421.81 |
| Sep 30, 2021 | -1.69 Mn |